valyl-tyrosyl-prolyl-asparaginyl-glycyl-alanine: a fragment of adrenocorticotropic hormone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5487182 |
| MeSH ID | M0235404 |
| Synonym |
|---|
| vypnga |
| (2s)-2-[[2-[[(2s)-4-amino-2-[[(2s)-1-[(2s)-2-[[(2s)-2-amino-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoyl]amino]acetyl]amino]propanoic acid |
| n-(n-(n2-(1-(n-l-valyl-l-tyrosyl)-l-prolyl)-l-asparaginyl)glycyl)-l-alanine |
| 105760-58-5 |
| valyl-tyrosyl-prolyl-asparaginyl-glycyl-alanine |
| val-tyr-pro-asn-gly-ala |
| l-alanine, n-(n-(n2-(1-(n-l-valyl-l-tyrosyl)-l-prolyl)-l-asparaginyl)glycyl)- |
| DTXSID30147316 |
| l-val-l-tyr-l-pro-l-asn-gly-l-ala |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||